[1] Cheng X, Roberts RJ.AdoMet-dependent methylation, DNA methyltransferase and base flipping[J].NucleicAcids Res, 2001, 29(18):3784-3795. [2] Jeltsch A.Beyond Watson and Crick:DNA methylation and molecular enzymology of DNA methy ltransferases[J]. Chembiochem, 2002, 3(4):274-293. [3] Kanai Y, Ushijima S, Nakanishi Y, et al.Mutation of the DNA methy ltransferase (DNMT) 1 gene in human colorectal cancers[J].Cancer Lett, 2003, 192(1):75-82. [4] Sardi I, Dal-Canto M, Bartoletti R, et al.Molecular genetic alterations of c-my c oncogene in superficial and locally advanced bladder cancer[J].Eur Urol, 1998, 33(4):424-430. [5] Gupta A, Godwin AK, Vanderveer L, et al.Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression breast carcinoma and ovarian carcinoma[J].Cancer Res, 2003, 63(3):664-673. [6] Jones PA.DNA methylation and cancer[J].Oncogene, 2002, 21(35):5358-5360. [7] Gonzalez-Zulueta M, Bender CM, Yang AS, et al.Methylation of the 5'CpG island of the p16 CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing[J].Cancer Res, 1995, 55(20):4531-4535. [8] Momparler RL.Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine)[J].Semin Oncol, 2005, 32(5):443-451. [9] Murgo AJ.Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs[J].Semin Oncol, 2005, 32(5):458-464. [10] Laird PW, Jackson-Grusby L, Fazeli A, et al.Suppression of intestinal neoplasia by DNA hypomethylation[J]. Cell, 1995, 81(2):197-205. [11] Wassenegger M, Heimes S, Riedel L, et al.RNA-directed de novo methylation of genomic sequences in plants[J]. Cell, 1994, 76(3):567-576. [12] Sijen T, Vijn I, Rebocho A, et al.Transcriptional and posttranscriptional gene silencing are mechanistically related[J].Curr Biol, 2001, 11(6):436-440. [13] Kawasaki H, Taira K.Induction of DNA methylation and gene silencing by short interfering RNAs in human cells[J].Nature, 2004, 431(7005):211-217. [14] Morris KV, Chan SW, Jacobsen SE, et al.Small interfering RNA-induced transcriptional gene silencing in human cells[J].Science, 2004, 305(5688):1289-1292. [15] Kawasaki H, Taira K, Morris KV.siRNA induced transcriptional gene silencing in mammalian cells[J].Cell Cycle, 2005, 4(3):442-448. [16] Castanotto D, Tommasi S, Li M, et al.Short hairpin RNA-directed cytosine(CpG) methylation of the RASSF1A gene promoter in HeLa cells[J].Mol Ther, 2005, 2(1): 179-183. [17] Yao XM, Hu JF, Dabueks M, et al.A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma[J].J Clin Invest, 2003, 111(2):265-273. [18] Mita AC, Mita MM, Nawrocki ST, et al.survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J].Clin Cancer Res, 2008, 14(16): 5000-5005. [19] Warnecke PM, Stirzaker C, Song J, et al.Identification and resolution of artifacts in bisulfite sequencing[J]. Methods, 2002, 27(2):101-107. [20] Wells J, Farnham PJ.Characterizing transcription factor binding sites using formaldehyde crosslinking and immuynoprecipition[J].Methods, 2002, 26(1):48-56. [21] Lachner M, O'Sullivan RJ, Jenuwein T.An epigenetic road map for histone lysine methylation[J].J Cell Sci, 2003, 116(Pt 11):2117-2124. [22] Quina AS, Buschbeck M, Di Croce L.Chromatin structure and epigenetics[J].Biochem Pharmacol, 2006, 72(11):1563-1569. |